Share
Market Research Report

NEUPOGEN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By IndicationChemotherapy-induced neutropenia in non-myeloid malignancies · Neutropenia in acute myeloid leukemia (AmL) patients post induction or consolidation chemotherapy · Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT) · Mobilization of autologous hematopoietic progenitor cells for leukapheresis · Chronic neutropenia (congenital, cyclic, idiopathic) · and Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)
  • By Dose Strength300mcg/1mL · 480mcg/1.6mL · 300MGC/0.5mL · and 480mcg/0.8mL
  • By PackagingSingle-use vials and Prefilled syringes
  • By Patient Age GroupPediatric · Adult · and Geriatric
  • By Sales ChannelOnline and Offline
  • By End UserHospitals · Oncology Clinics · Ambulatory Surgical Centers · and Others (Academic & Research Institutions, etc.)
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In11 Mar 2026
  • Report CodeCMI8115
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Indication Insights (Revenue, USD Mn, 2021 - 2033)

    • Chemotherapy-induced neutropenia in non-myeloid malignancies
    • Neutropenia in acute myeloid leukemia (AmL) patients post-induction or consolidation chemotherapy
    • Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT)
    • Mobilization of autologous hematopoietic progenitor cells for leukapheresis
    • Chronic neutropenia (congenital, cyclic, idiopathic)
    • Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)

  •  Dose Strength Insights (Revenue, USD Mn, 2021 - 2033)

    • 300mcg/1mL
    • 480mcg/1.6mL
    • 300MGC/0.5mL
    • 480mcg/0.8mL

  •  Packaging Insights (Revenue, USD Mn, 2021 - 2033)

    • Single-use vials
    • Prefilled syringes

  •  Patient Age Group Insights (Revenue, USD Mn, 2021 - 2033)

    • Pediatric
    • Adult
    • Geriatric

  •  Sales Channel Insights (Revenue, USD Mn, 2021 - 2033)

    • Online
    • Offline

  •  End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospitals
    • Oncology Clinics
    • Ambulatory Surgical Centers
    • Others (Academic & Research Institutions, etc.)

  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa